Beyond lipid metabolism, fetuin-A has been implicated in promoting insulin resistance by inhibiting insulin receptor tyrosine kinase activity, and in amplifying systemic inflammation through activation of Toll-like receptor 4 pathways. Here, AHSG is linked to Insulin resistance.